MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)
Hong Kong
· Delayed Price · Currency is HKD 6.36
-0.13 (-2.00%)
May 9, 2025, 3:32 PM HKT
HKG:2235 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Operating Revenue | 340.35 | 248.35 | 169.89 | 151.4 | 75.28 | Upgrade
|
| Other Revenue | 5.26 | 4.88 | 3.72 | - | - | Upgrade
|
| Revenue | 345.62 | 253.23 | 173.61 | 151.4 | 75.28 | Upgrade
|
| Revenue Growth (YoY) | 36.48% | 45.86% | 14.67% | 101.13% | 45.15% | Upgrade
|
| Cost of Revenue | 166.54 | 136.08 | 93.91 | 80.52 | 38.73 | Upgrade
|
| Gross Profit | 179.08 | 117.14 | 79.69 | 70.88 | 36.54 | Upgrade
|
| Selling, General & Admin | 249.28 | 250.62 | 158.23 | 93.74 | 100.82 | Upgrade
|
| Research & Development | 76.56 | 70.1 | 61.09 | 36.08 | 82.01 | Upgrade
|
| Other Operating Expenses | -0.79 | -9.28 | -21.99 | - | - | Upgrade
|
| Operating Expenses | 326.49 | 312.43 | 200.04 | 131.05 | 183.01 | Upgrade
|
| Operating Income | -147.41 | -195.29 | -120.34 | -60.17 | -146.47 | Upgrade
|
| Interest Expense | -0.68 | -0.05 | -0.15 | -0.02 | -0.31 | Upgrade
|
| Interest & Investment Income | 64.25 | 68.24 | 55.72 | 24.49 | 8.14 | Upgrade
|
| Currency Exchange Gain (Loss) | 9.7 | 7.11 | 29.95 | -16.48 | -2.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.3 | -4.68 | -0.22 | 3.97 | 19.26 | Upgrade
|
| EBT Excluding Unusual Items | -74.44 | -124.67 | -35.03 | -48.2 | -121.48 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.09 | -0.02 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.01 | 0.05 | 0.23 | Upgrade
|
| Asset Writedown | -0.83 | -0.16 | -0 | - | - | Upgrade
|
| Other Unusual Items | 12.03 | 0 | - | - | - | Upgrade
|
| Pretax Income | -63.15 | -124.85 | -35.04 | -48.15 | -121.25 | Upgrade
|
| Income Tax Expense | -0.03 | 0.16 | 0 | - | - | Upgrade
|
| Earnings From Continuing Operations | -63.12 | -125.02 | -35.04 | -48.15 | -121.25 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | 0.24 | Upgrade
|
| Net Income | -63.12 | -125.02 | -35.04 | -48.15 | -121.01 | Upgrade
|
| Net Income to Common | -63.12 | -125.02 | -35.04 | -48.15 | -121.01 | Upgrade
|
| Shares Outstanding (Basic) | 418 | 431 | 438 | 373 | 306 | Upgrade
|
| Shares Outstanding (Diluted) | 418 | 431 | 438 | 373 | 306 | Upgrade
|
| Shares Change (YoY) | -3.05% | -1.59% | 17.39% | 21.79% | - | Upgrade
|
| EPS (Basic) | -0.15 | -0.29 | -0.08 | -0.13 | -0.39 | Upgrade
|
| EPS (Diluted) | -0.15 | -0.29 | -0.08 | -0.13 | -0.39 | Upgrade
|
| Free Cash Flow | -120.65 | -153 | -148.79 | -61.82 | -35.23 | Upgrade
|
| Free Cash Flow Per Share | -0.29 | -0.35 | -0.34 | -0.17 | -0.12 | Upgrade
|
| Gross Margin | 51.81% | 46.26% | 45.91% | 46.82% | 48.55% | Upgrade
|
| Operating Margin | -42.65% | -77.12% | -69.32% | -39.74% | -194.58% | Upgrade
|
| Profit Margin | -18.26% | -49.37% | -20.18% | -31.80% | -160.75% | Upgrade
|
| Free Cash Flow Margin | -34.91% | -60.42% | -85.71% | -40.83% | -46.80% | Upgrade
|
| EBITDA | -136.21 | -184.12 | -110.19 | -52.28 | -141.52 | Upgrade
|
| EBITDA Margin | -39.41% | -72.71% | -63.47% | -34.53% | -188.00% | Upgrade
|
| D&A For EBITDA | 11.2 | 11.17 | 10.15 | 7.88 | 4.95 | Upgrade
|
| EBIT | -147.41 | -195.29 | -120.34 | -60.17 | -146.47 | Upgrade
|
| EBIT Margin | -42.65% | -77.12% | -69.32% | -39.74% | -194.58% | Upgrade
|
| Revenue as Reported | 345.62 | 253.23 | 173.61 | - | - | Upgrade
|
Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.